US Broker Ratings

Immutep Limited (IMMP) Stock Analysis: Unveiling a 370% Upside Potential in Biotechnology

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, is making waves in the healthcare sector with its innovative Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies. With a market capitalization of $296.51..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 62.87% Potential Upside in the Innovative Medical Device Sector

Outset Medical, Inc. (NASDAQ: OM), a promising player in the healthcare sector, has captured the attention of investors with its innovative approach to hemodialysis. The company, headquartered in San Jose,..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating Growth Potential Amidst Market Challenges

Investors eyeing opportunities in the healthcare sector might find Cytek Biosciences, Inc. (NASDAQ: CTKB) an intriguing prospect, particularly given its innovative approach to cell analysis solutions. As a company operating..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Exploring Its Niche in Immuno-Oncology with a Market Cap of $448 Million

iTeos Therapeutics, Inc. (NASDAQ: ITOS) is a name that stands out in the biotechnology industry, primarily focusing on the rapidly evolving field of immuno-oncology. Based in Watertown, Massachusetts, this clinical-stage..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: A 251.85% Upside Potential That Investors Can’t Ignore

Heron Therapeutics, Inc. (NASDAQ: HRTX), a prominent player in the biotechnology sector, presents a compelling case for investors seeking a high-risk, high-reward opportunity. With a market cap of $247.47 million..

A2Z Cust2Mate Solutions Corp. (AZ): Investor Outlook Reveals a Promising 166% Upside Potential

For investors seeking innovative opportunities in the tech sector, A2Z Cust2Mate Solutions Corp. (AZ) presents an intriguing case. The Canadian company, with a current market cap of $314.15 million, operates..

SoundHound AI, Inc. (SOUN) Stock Analysis: A Glimpse into Its Revenue Surge and Market Dynamics

SoundHound AI, Inc. (NASDAQ: SOUN) is carving a niche in the technology sector with its cutting-edge voice artificial intelligence (AI) solutions. Headquartered in Santa Clara, California, SoundHound is renowned for..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 43% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is making waves in the healthcare sector with its cutting-edge sequencing solutions, capturing the attention of investors seeking a blend of innovation and..

UroGen Pharma Ltd. (URGN) Stock Analysis: Unpacking the 94.75% Potential Upside

For investors eyeing the biotechnology landscape, UroGen Pharma Ltd. (NASDAQ: URGN) presents a compelling opportunity. With a market capitalization of $801.76 million, this healthcare company is making strides in the..

TotalEnergies SE (TTE) Stock Analysis: Uncovering a 16.42% Upside Potential for Investors

TotalEnergies SE (TTE) is making waves in the energy sector with a compelling investment narrative that holds promise for both stability and growth. As the integrated oil and gas giant..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 116% Potential Upside with Strong Buy Ratings

Viant Technology Inc. (NASDAQ: DSP) is drawing significant attention from investors, not only for its innovative role in the advertising technology space but also for its substantial upside potential. With..

Alumis Inc. (ALMS) Investor Outlook: Exploring a 328.89% Potential Upside in the Biotech Sector

Alumis Inc. (NASDAQ: ALMS), a dynamic player in the biotechnology sector, has captured the attention of investors with its promising pipeline focused on autoimmune disorders. Based in South San Francisco,..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook Highlights Robust 43% Upside Potential

Individual investors with a keen eye for opportunities in the biotechnology sector may find Tvardi Therapeutics, Inc. (NASDAQ: TVRD) an intriguing pick, given its substantial upside potential. With a promising..

Erasca, Inc. (ERAS) Stock Analysis: Unlocking an 88% Potential Upside in the Biotech Sector

Erasca, Inc. (NASDAQ: ERAS) is capturing the interest of investors with its strategic focus on precision oncology and a potential upside of 88.12%, as indicated by analyst ratings. The company’s..

Neuronetics, Inc. (STIM) Stock Report: Healthcare Innovator with 118.86% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the healthcare sector, is drawing significant attention from investors eager to capitalize on potential upside opportunities. With a market capitalization of $196.39..

Sanara MedTech Inc. (SMTI): Investor Outlook Reveals 54% Potential Upside in Healthcare Innovator

Sanara MedTech Inc. (NASDAQ: SMTI), a dynamic player in the healthcare sector, is capturing the attention of individual investors with its promising growth potential. Based in Fort Worth, Texas, Sanara..

Anbio Biotechnology (NNNN) Stock Report: Navigating a Tumultuous Year Amidst a 52-Week Price Fluctuation

Anbio Biotechnology, trading under the symbol NNNN, has captured the attention of investors with its impressive 52-week price range and innovative product line. Based in Frankfurt am Main, Germany, this..

Aura Biosciences, Inc. (AURA): Biotechnology Stock with 248% Upside Potential Draws Investor Attention

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company based in Boston, Massachusetts, is capturing investor interest with its innovative approach to treating solid tumors. The company’s proprietary platform leverages..

Nyxoah SA (NYXH) Stock Analysis: A Compelling Investment with 108% Potential Upside

Nyxoah SA (NASDAQ: NYXH) presents a fascinating opportunity for investors looking to capitalize on the burgeoning healthcare sector, specifically within the medical instruments and supplies industry. Based in Belgium, Nyxoah..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 50% Upside in the Innovative Medical Device Sector

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector with its cutting-edge advancements in medical devices, particularly through its focus on Next Generation Protein Sequencing (NGPS). Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds